Search

Your search keyword '"Amadori, D."' showing total 1,152 results

Search Constraints

Start Over You searched for: Author "Amadori, D." Remove constraint Author: "Amadori, D."
1,152 results on '"Amadori, D."'

Search Results

1. The Mathematical Theory of Hughes’ Model: A Survey of Results

2. The Mathematical Theory of Hughes’ Model: A Survey of Results

3. An Integro-Differential Conservation Law arising in a Model of Granular Flow

4. IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab

6. Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial

7. Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas

8. Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas

10. First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma

11. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

12. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial

15. Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature

21. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

25. Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies

30. Gliding in the Amazonian canopy: adaptive evolution of flight inMorphobutterflies

31. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial

33. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

34. Sottoprodotti agroalimentari valorizzati con le mosche soldato

41. Impact of Ki67 and progesterone receptor on PFS with cyclin-dependent kinase 4/6 inhibitors in HER2-negative advanced breast cancer: A real world mono-institutional experience

42. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Catalog

Books, media, physical & digital resources